Company: ANIX
Filing Date: 2025-12-12
Form Type: 8-K
Source: 0001493152-25-027321
Chunk: 0

Company: Anixa Biosciences Inc
Filing Date: 2025-12-12
Form: 8-K
Item: Item 7.01
Chunk 0
---
Item       Regulation      

On
December 11, 2025, Anixa Biosciences, Inc. (“we,” “us,” “our,” or the “ Company”) issued
a press release announcing that the Company and The Cleveland Clinic Foundation (“ Cleveland Clinic”) presented final data
from the Phase 1 clinical trial of its investigational breast cancer vaccine. The press release, which is furnished as Exhibit 99.1 hereto,
was issued following a presentation made by Justin Johnson, Ph. D., Program Manager at Cleveland Clinic and co-inventor of the breast
cancer vaccine technology. Furnished hereto as Exhibit 99.2 is the presentation abstract utilized by Dr. Johnson for the presentation.

Statements
that are not historical fact may be considered forward-looking statements within the meaning of the Private Securities Litigation Reform
Act of 1995. Forward-looking statements are not statements of historical facts, but rather reflect our current expectations concerning
future events and results. We generally use the words “believes,” “expects,” “intends,” “plans,”
“anticipates,” “likely,” “will” and similar expressions to identify forward-looking statements. Such
forward-looking statements, including those concerning our clinical trials, involve risks, uncertainties and other factors, some of which
are beyond our control, which may cause our actual results, performance or achievements, or industry results, to be materially different
from any future results, performance, or achievements expressed or implied by such forward-looking statements. These risks, uncertainties
and factors include, but are not limited to, those factors set forth in “ Item 1A - Risk Factors” and other sections of our
most recent Annual Report on Form 10-K as well as in our Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. We undertake
no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise,
except as required by law. You are cautioned not to unduly rely on such forward-looking statements when evaluating the information presented
in this Current Report.